INS and Cushing syndrome: Among patients suffering from Cushing’s syndrome, over 30% will develop diabetes [28], associated with an impaired glucose tolerance and a decrease in insulin sensitivity prior to the clinical stage of the disease, suggesting that some individuals are more likely prone to develop diabetes in response to supraphysiological GC doses.